Introduction                                entrar

Chapter 1. Ethical Considerations

Chapter 2. Good Clinical Practice

Chapter 3. Assessment of Endpoints: Kinetics and/or Dynamics

Chapter 4. Pharmacogenetics and Pharmacogenomics

Chapter 5. Paediatric Drug Research

Chapter 6. Phase I (human Pharmacology)

Chapter 7. Follow-Up of Drugs After Market Entry

Chapter 8. Bioavailability and Bioequivalence

Chapter 9. Pharmacoeconomics and Economic Evaluation of Drug Therapies

Chapter 10. Drug Utilization

Pharmacological Research in Cardiovascular Disorders

Chapter 11. Hypertensive Vascular Disease

Chapter 12. Lipid Lowering Agents

Chapter 13. Anti-atherosclerotic Drugs

Chapter 14. Heart Failure

Chapter 15. Arrhythmias

Pharmacological Research in Neurologic Disorders

Chapter 16. Epilepsies and Convulsive Disorders

Chapter 17. Headache Disorders

Chapter 18. Alzheimer’s Disease and Other Dementias

Chapter 19. Parkinson’s Disease and Other Extrapyramidal Disorders

Chapter 20. Multiple Sclerosis and Other Demyelinating Diseases

Pharmacological Research in Mental Disorders

Chapter 21. Mood Disorders

Chapter 22. Anxiety Disorders

Chapter 23. Schizophrenic Disorders

Chapter 24. Alcoholism and Nicotine Addiction

Pharmacological Reasearch in Joint Disorders

Chapter 25. Osteoarthritis / arthrosis Short Term Studies

Chapter 26. Osteoarthritis / arthrosis Long Term Studies

Chapter 27. Rheumatoid Arthritis

Pharmacological Research in Other Disorders

Chapter 28.  Neoplastic Diseases

Chapter 29. Analgesic Drugs for Cancer Pain Management

Chapter 30. Drugs Used in Osteoporosis